121 related articles for article (PubMed ID: 10746940)
21. Alteration in sexually dimorphic testosterone biotransformation profiles as a biomarker of chemically induced androgen disruption in mice.
Wilson VS; McLachlan JB; Falls JG; LeBlanc GA
Environ Health Perspect; 1999 May; 107(5):377-84. PubMed ID: 10210693
[TBL] [Abstract][Full Text] [Related]
22. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
[TBL] [Abstract][Full Text] [Related]
23. Evidence that famciclovir (BRL 42810) and its associated metabolites do not inhibit the 6 beta-hydroxylation of testosterone in human liver microsomes.
Harrell AW; Wheeler SM; Pennick M; Clarke SE; Chenery RJ
Drug Metab Dispos; 1993; 21(1):18-23. PubMed ID: 8095215
[TBL] [Abstract][Full Text] [Related]
24. Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
Cadario BJ; Bellward GD; Bandiera S; Chang TK; Ko WW; Lemieux E; Pak RC
Mol Pharmacol; 1992 May; 41(5):981-8. PubMed ID: 1588929
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
[TBL] [Abstract][Full Text] [Related]
26. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
27. Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (Halichoerus grypus).
Li H; Boon JP; Lewis WE; van den Berg M; Nyman M; Letcher RJ
Environ Toxicol Chem; 2003 Mar; 22(3):636-44. PubMed ID: 12627653
[TBL] [Abstract][Full Text] [Related]
28. Hepatic effects of ketoconazole in the male Swiss Webster mouse: temporal changes in drug metabolic parameters.
Whitehouse LW; Pakuts AP; Paul CJ; Mueller RW; Thomas BH
Can J Physiol Pharmacol; 1990 Aug; 68(8):1136-42. PubMed ID: 2390740
[TBL] [Abstract][Full Text] [Related]
29. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
Gentile DM; Verhoeven CH; Shimada T; Back DJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
[TBL] [Abstract][Full Text] [Related]
30. A comparison of cytochrome P450-dependent testosterone 2alpha-hydroxylase in rat (P4502C11) and mouse (P4502alpha).
Sharma MC; Sharma MR; Shapiro BH
Pharmacology; 1998 Feb; 56(2):71-9. PubMed ID: 9494065
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
Shiverick KT
Drug Metab Dispos; 1981; 9(6):545-50. PubMed ID: 6120814
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide.
May-Manke A; Kroemer H; Hempel G; Bohnenstengel F; Hohenlöchter B; Blaschke G; Boos J
Cancer Chemother Pharmacol; 1999; 44(4):327-34. PubMed ID: 10447581
[TBL] [Abstract][Full Text] [Related]
34. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9.
Baldwin SJ; Bloomer JC; Smith GJ; Ayrton AD; Clarke SE; Chenery RJ
Xenobiotica; 1995 Mar; 25(3):261-70. PubMed ID: 7618352
[TBL] [Abstract][Full Text] [Related]
35. Androgen-responsive functions of male rat liver. Effect of chronic alcohol ingestion.
Eagon PK; Willett JE; Seguiti SM; Appler ML; Gavaler JS; Van Thiel DH
Gastroenterology; 1987 Dec; 93(6):1162-9. PubMed ID: 3678734
[TBL] [Abstract][Full Text] [Related]
36. The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation.
Chang TK; Teixeira J; Gil G; Waxman DJ
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):429-33. PubMed ID: 8484723
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs.
Kan PB; Hirst MA; Feldman D
J Steroid Biochem; 1985 Dec; 23(6A):1023-9. PubMed ID: 3841572
[TBL] [Abstract][Full Text] [Related]
38. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
[TBL] [Abstract][Full Text] [Related]
39. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
Fischer V; Rodríguez-Gascón A; Heitz F; Tynes R; Hauck C; Cohen D; Vickers AE
Drug Metab Dispos; 1998 Aug; 26(8):802-11. PubMed ID: 9698296
[TBL] [Abstract][Full Text] [Related]
40. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
